辰欣药业(603367.SH)：石四药拟减持不超过1%股份

Core Viewpoint - Chenxin Pharmaceutical (603367.SH) announced that Shisi Pharmaceutical plans to reduce its holdings within three months after a 15 trading day period from the announcement date, depending on market conditions [1] Summary by Relevant Sections - Reduction Plan - Shisi Pharmaceutical intends to reduce its holdings through centralized bidding transactions - The number of shares to be reduced will not exceed 4,527,000 shares within any continuous 90-day period - The reduction will not exceed 1% of the company's total share capital [1] - Adjustment Conditions - The reduction plan will be adjusted accordingly if the company undergoes any events such as capital increase, dividend distribution, stock bonus, capital reserve conversion to share capital, or rights issue during the reduction period [1]